Treatment Options for Prostate Cancer
BY MARK SCHOLZ, MD Selecting treatment for prostate cancer is complex. Start by taking the Staging Quiz (keytopc.com). This is the first-step to understanding proper management. Once you know your …
Active Surveillance
BY MARK SCHOLZ,MD A Cancer that Can be Watched If someone tells you your cancer can be watched instead of treated, your initial reaction might be that they have no …
Stay Away from Random Prostate Biopsy
BY MARK SCHOLZ, MD The Limitations of PSA PSA is nonspecific. Meaning it doesn’t distinguish between the harmless, low-grade type of prostate cancer that can be watched and the higher-grade …
Counteracting Side Effects from Hormonal Therapy
BY MARK SCHOLZ, MD Hormonal therapy can slow or even halt prostate cancer growth, but it isn’t without its side effects. Many measures—from medication to exercise—can mitigate these secondary reactions. …
Testosterone Inactivating Pharmaceuticals (TIP)
BY MARK SCHOLZ, MD Hormones play a large role in cancer growth. They are also integral to treatment. Testosterone is a key player. It originates mostly in the testicles and, …
Making an Informed Decision about Prostate Cancer
BY MARK SCHOLZ, MD What Is the Best Therapy for Me? This is one of the greatest questions for men with prostate cancer. How do you arrive at a reliable …
Breakthroughs for Hormone-Resistant Prostate Cancer
BY MARK SCHOLZ, MD The value of a new medical treatment is gauged by the seriousness of the problem it overcomes. Hormone-resistant prostate cancer—that is, prostate cancer that has become …
10 Myths of Prostate Cancer
BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …
Treatable for Low Risk or Very Low Risk Prostate Cancer Type?
BY RICHARD LAM, MD https://youtu.be/Zhw8qrg9Bi0 Yes. It’s definitely treatable and will be successful treated. Of course the concern with treatment – there are potential very long-term detrimental side effects. One’s …
Selecting the Best Therapy for Newly-Diagnosed Prostate Cancer
BY MARK SCHOLZ, MD Due to the absence of well-designed comparative studies, treatment selection for prostate cancer has been highly controversial. However, in October 2016, two landmark articles published in the New England …